Global Justice with Respect to Pharmaceuticals

Panel

Panel 4: Drug Cost and Access II

Moderator

Gordian Hasselblatt, Partner, CMS Hasche Sigle

Description

I am going to tackle the question, if there is a global justice, how we can conceptualize it and apply it on the distribution of pharmaceutical products. As a preliminary result, I am going to defend the thesis that we can indeed speak of such a principle. It balances the freedom of the holders of intellectual property rights on pharmaceutical products with the equality of the lesser advantaged people according to the principle of human dignity.

Speaker Bio

Stephan Kirste is university-professor for Legal and Social Philosophy at the Department for Business, Economics and Social Theory in the Faculty of Law of the Paris Lodron University of Salzburg, Austria. He is president of the German Section of the International Association for Legal and Social Philosophy (IVR). Promoted Dr. iur. at the University of Freiburg (Germany); Habilitation at the University of Heidelberg (Germany). His fields of interest concern in particular: Theory of jurisprudence (esp. interdisciplinarity of the science of law); Theory of law (esp. law and time); ethics of law (esp. human rights, human dignity, and justice); Comparative constitutional law (esp. Brazil, USA); history of legal thought.

His main publications can be found here: https://www.uni-salzburg.at/index.php?id=31224

Location

Pacific McGeorge School of Law, Lecture Hall, 3200 Fifth Ave., Sacramento, CA

This document is currently not available here.

Share

COinS
 
Apr 5th, 11:45 AM Apr 5th, 1:30 PM

Global Justice with Respect to Pharmaceuticals

Pacific McGeorge School of Law, Lecture Hall, 3200 Fifth Ave., Sacramento, CA

I am going to tackle the question, if there is a global justice, how we can conceptualize it and apply it on the distribution of pharmaceutical products. As a preliminary result, I am going to defend the thesis that we can indeed speak of such a principle. It balances the freedom of the holders of intellectual property rights on pharmaceutical products with the equality of the lesser advantaged people according to the principle of human dignity.